These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1546726)

  • 1. Estrogen replacement therapy and the risk of venous thrombosis.
    Devor M; Barrett-Connor E; Renvall M; Feigal D; Ramsdell J
    Am J Med; 1992 Mar; 92(3):275-82. PubMed ID: 1546726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of venous thromboembolism in users of hormone replacement therapy.
    Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
    Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risk: effects of estrogen replacement therapy and body mass.
    Harris RE; Namboodiri KK; Wynder EL
    J Natl Cancer Inst; 1992 Oct; 84(20):1575-82. PubMed ID: 1404451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
    Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
    Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
    JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
    Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH
    Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HRT and the risk of deep vein thrombosis.
    Barlow DH
    Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S29-33. PubMed ID: 9386213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study of venous thromboembolism risk in users of hormone replacement therapy.
    Daly E; Vessey MP; Painter R; Hawkins MM
    Lancet; 1996 Oct; 348(9033):1027. PubMed ID: 8855869
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen replacement therapy is not conducive of venous thromboembolism.
    Young RL; Goepfert AR; Goldzieher HW
    Maturitas; 1991 Sep; 13(3):189-92. PubMed ID: 1943826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thrombosis and conjugated equine estrogen in women without a uterus.
    Curb JD; Prentice RL; Bray PF; Langer RD; Van Horn L; Barnabei VM; Bloch MJ; Cyr MG; Gass M; Lepine L; Rodabough RJ; Sidney S; Uwaifo GI; Rosendaal FR
    Arch Intern Med; 2006 Apr; 166(7):772-80. PubMed ID: 16606815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy is not a risk for venous thrombosis.
    Forbes CD; Greer IA
    Scott Med J; 1994 Dec; 39(6):165-6. PubMed ID: 8778977
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.
    Varas-Lorenzo C; García-Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Perez-Gutthann S
    Am J Epidemiol; 1998 Feb; 147(4):387-90. PubMed ID: 9508106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
    Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for fatal venous thromboembolism in young women: a case-control study.
    Thorogood M; Mann J; Murphy M; Vessey M
    Int J Epidemiol; 1992 Feb; 21(1):48-52. PubMed ID: 1544757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy is not a risk for venous thrombosis.
    Lip GY; Beevers M; Zarifis J; Beevers G
    Scott Med J; 1995 Feb; 40(1):30. PubMed ID: 7604241
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.
    Castellsague J; Pérez Gutthann S; García Rodríguez LA
    Drug Saf; 1998 Feb; 18(2):117-23. PubMed ID: 9512918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of thrombosis due to oral contraceptives: a further report.
    Maguire MG; Tonascia J; Sartwell PE; Stolley PD; Tockman MS
    Am J Epidemiol; 1979 Aug; 110(2):188-95. PubMed ID: 463873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.